One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Camille Vanessa EdwardsDivaya BhutaniMarkus MaparaJai RadhakrishnanSofia ShamesMathew S MaurerSiyang LengJonathan S WallAlan SolomonAndrew EisenbergerSuzanne LentzchPublished in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2020)